Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations.

Publication

Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations.

Journal Paper/Review - Dec 23, 2022

Schaub Cédéric, Barnsteiner Stefanie, Schönenberg Ladina, Bloch Nando, Dräger Sarah, Albrich Werner, Conen Anna, Osthoff Michael

Citation

Schaub C, Barnsteiner S, Schönenberg L, Bloch N, Dräger S, Albrich W, Conen A, Osthoff M. Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations. J Glob Antimicrob Resist 2022; 32:11-17.

Type

Journal Paper/Review (English)

Journal

J Glob Antimicrob Resist 2022; 32

Publication Date

Dec 23, 2022

Issn Electronic

2213-7173

Pages

11-17

Brief description/objective

Shortening the duration of antibiotic therapy (DAT) for common infectious diseases may be an effective strategy to tackle antimicrobial resistance. Shorter DAT has been proven safe and effective for community-acquired pneumonia (CAP), cellulitis, and cholangitis.